Gladius Capital Management LP Elanco Animal Health Inc Transaction History

Gladius Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 18, 2023	SELL	$9.81 - $12.62 $559 - $719	-57 Reduced 2.27%	2,457 $27,000
Q3 2023 Oct 10, 2023	SELL	$9.81 - $12.62 $559 - $719	-57 Reduced 2.27%	2,457 $28,000
Q2 2023 Dec 18, 2023	BUY	$8.08 - $10.37 $460 - $591	57 Added 2.32%	2,514 $25,000
Q2 2023 Aug 08, 2023	SELL	$8.08 - $10.37 $824 - $1,057	-102 Reduced 3.9%	2,514 $26,000
Q1 2023 Dec 18, 2023	BUY	$8.79 - $14.58 $1,397 - $2,318	159 Added 6.47%	2,616 $24,000
Q1 2023 May 09, 2023	SELL	$8.79 - $14.58 $2,540 - $4,213	-289 Reduced 9.95%	2,616 $25,000
Q4 2022 Dec 18, 2023	BUY	$11.49 - $13.65 $5,147 - $6,115	448 Added 18.23%	2,905 $35,000
Q4 2022 Feb 02, 2023	BUY	$11.49 - $13.65 $5,986 - $7,111	521 Added 21.85%	2,905 $36,000
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $17,535 - $45,809	1,413 Added 145.52%	2,384 $30,000
Q2 2022 Aug 10, 2022	BUY	$19.63 - $26.62 $19,060 - $25,848	971 New	971 $20,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.71B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.